| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.16 | 2e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.23 | 0.0002 |